"."

During the past decade, Ospedale Regionale Di Parma; Divisione Di Oncologia Medica conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 11 clinical trials were completed, i.e. on average, 61.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Regionale Di Parma; Divisione Di Oncologia Medica" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Gruppo Oncologico Italiano di Ricerca Clinica" with 6 trials sponsored, "Gruppo Oncologico del Nord-Ovest" with 3 trials sponsored, "Fondazione Ricerca Traslazionale" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Regionale Di Parma; Divisione Di Oncologia Medica" #1 collaborator was "Istituto Toscano Tumori" with 2 trials as a collaborator, "Temas srl" with 2 trials as a collaborator, "YGHEA, CRO Division of Ecol Studio spa" with 2 trials as a collaborator, "AOU S. Orsola Malpighi - Clinical Trial Office" with 1 trials as a collaborator and "AOU S.Orsola Malpighi-Unit of Oncologic Molecular and Transplantations Pathology" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Regionale Di Parma; Divisione Di Oncologia Medica" are "Non-Small Cell Lung Cancer" (5 trials), "Colorectal Cancer" (3 trials), "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "Metastatic Colorectal Cancer" (2 trials). Many other conditions were trialed in "Ospedale Regionale Di Parma; Divisione Di Oncologia Medica" in a lesser frequency.

Most popular intervention types in "Ospedale Regionale Di Parma; Divisione Di Oncologia Medica" are "Drug" (28 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (8 trials), "Bevacizumab" (5 trials), "Pertuzumab" (5 trials), "Docetaxel" (4 trials) and "Placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Regionale Di Parma; Divisione Di Oncologia Medica" are 25 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Ospedale Regionale Di Parma; Divisione Di Oncologia Medica". undefined are not yet recruiting, 4 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Ospedale Regionale Di Parma; Divisione Di Oncologia Medica, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Regionale Di Parma; Divisione Di Oncologia Medica, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".